Post herpetic neuralgia

Journal of Palliative Medicine

Volumn 14, Issue 6, 2011, Pages 765-773

  Philip, Annie ^a,b   Thakur, Rajbala ^a  

^a UNIVERSITY OF ROCHESTER SCHOOL OF MEDICINE AND DENTISTRY   (United States)

^b UNIVERSITY OF ROCHESTER   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ACETYLSALICYLIC ACID; AMITRIPTYLINE; ANTIVIRUS AGENT; CAPSAICIN; CHICKENPOX VACCINE; CORTICOSTEROID; DESIPRAMINE; DICLOFENAC; DULOXETINE; ETHER; ETIRACETAM; FENTANYL; GABAPENTIN; INDOMETACIN; LIDOCAINE; METHADONE; MORPHINE; NORTRIPTYLINE; OPIATE; OXYCODONE; PREGABALIN; TAPENTADOL; TOPIRAMATE; TRAMADOL; TRICYCLIC ANTIDEPRESSANT AGENT; UNINDEXED DRUG; VALPROIC ACID; VARICELLA ZOSTER VACCINE; VENLAFAXINE; ZONISAMIDE;

ACUPUNCTURE; ACUTE DISEASE; ADL DISABILITY; AGED; ALLODYNIA; ANESTHESIA; ANOREXIA; ANXIETY; APPLICATION SITE BURNING; APPLICATION SITE ERYTHEMA; APPLICATION SITE IRRITATION; BALANCE DISORDER; BEDTIME DOSAGE; BEHAVIOR THERAPY; BIOAVAILABILITY; BLISTER; BLOOD PRESSURE; BLURRED VISION; CARDIAC PATIENT; CENTRAL NERVOUS SYSTEM; CHICKENPOX; CLINICAL FEATURE; CONSTIPATION; CORDOTOMY; CRYOTHERAPY; DEPRESSION; DERMATOME; DESENSITIZATION; DIABETIC NEUROPATHY; DIALYSIS; DISEASE SEVERITY; DIZZINESS; DROWSINESS; DRUG ABSORPTION; DRUG ABUSE; DRUG BLOOD LEVEL; DRUG DEPENDENCE; DRUG DOSE TITRATION; DRUG EFFICACY; DRUG ELIMINATION; DRUG ERUPTION; DRUG INDUCED HEADACHE; DRUG SAFETY; DRUG TOLERABILITY; ELECTROCOAGULATION; ELECTROSTIMULATION; EUPHORIA; EYE DISEASE; FACIAL NERVE PARALYSIS; FATIGUE; GAIT DISORDER; HEART ARRHYTHMIA; HEART DISEASE; HEART PALPITATION; HERPES ZOSTER; HUMAN; HYPERALGESIA; HYPOGONADISM; IMMOBILIZATION; IMMUNOSUPPRESSIVE TREATMENT; INFECTION; INFLAMMATION; INSOMNIA; KIDNEY FAILURE; LIVER FUNCTION; MENTAL CONCENTRATION; MENTAL HEALTH; MULTIPLE CYCLE TREATMENT; MUSCLE ATROPHY; MUSCULOSKELETAL PAIN; NAUSEA; NAUSEA AND VOMITING; NERVE BLOCK; NERVE CELL; NERVE CONDUCTION; NEUROPATHIC PAIN; NOCICEPTIVE RECEPTOR; ORTHOSTATIC HYPOTENSION; PAIN; PATHOGENESIS; PATIENT AUTONOMY; PERIPHERAL EDEMA; PERIPHERAL NEUROPATHY; POLYNEUROPATHY; POSTHERPETIC NEURALGIA; PREVALENCE; PRURITUS; QT PROLONGATION; QUALITY OF LIFE; RANGE OF MOTION; RASH; RECOMMENDED DRUG DOSE; REVIEW; RISK FACTOR; SEDATION; SENESCENCE; SENSITIZATION; SENSORY GANGLION; SENSORY NERVE; SEROLOGY; SEX DIFFERENCE; SEXUAL DYSFUNCTION; SIDE EFFECT; SINGLE DRUG DOSE; SKIN BIOPSY; SKIN NERVE; SOCIAL BEHAVIOR; SOMNOLENCE; SPINAL CORD DORSAL HORN; SPINAL CORD STIMULATION; SPINAL GANGLION; SUICIDE; SYMPATHETIC BLOCKING; TACTILE DISCRIMINATION; TISSUE DEGENERATION; TISSUE INJURY; TRANSCUTANEOUS NERVE STIMULATION; UNSPECIFIED SIDE EFFECT; URINE RETENTION; VACCINATION; VARICELLA ZOSTER VIRUS; VIBRATION SENSE; VIRUS REACTIVATION; VIRUS REPLICATION; VOMITING; WEIGHT GAIN; WEIGHT REDUCTION; XEROSTOMIA;

EID: 79958190187     PISSN: 10966218     EISSN: 15577740     Source Type: Journal    
DOI: 10.1089/jpm.2011.9685     Document Type: Review

References (68)

1. Kimberlin DW, Whitely RJ: Varicella-zoster vaccine for the prevention of herpes zoster. N Eng J Med 2007;356:1338-1343. (Pubitemid 46513299)
2. Glynn C, Crockford G, Gavaghan D, Cardno P, Price D, Miller J: Epidemiology of shingles. J R Soc Med 1990;83:617.
3. Rusthoven JJ, Ahlgren P, Elhakin T, Pinfold P, Reid J, Stewart L, Feld R: Varicella-zoster infection in adult cancer patients: A population study. Arch Intern Med 1988; 148:1561.
4. Lydick E, Epstein RS, Himmelberger D, White CJ: Herpes zoster and quality of life: A self- limited disease with severe impact. Neurology 1995;45:S52.
5. Graff-Radford SB, Kames LD, Naliboff BD: Measure of psychological adjustment and perception of pain in post herpetic neuralgia and trigeminal neuralgia. Clin J Pain 1986;2:55.
6. Volpi A: Severe complications of herpes zoster. Herpes 2007;14(Suppl 2):35A-39A. (Pubitemid 47605619)
7. Volpi A, Gross G, Hercogova J, Johnson RW: Current management of herpes zoster. The European view. Am J Clin Dermatol 2005;6:317-325. (Pubitemid 41577406)
8. Watson CP, Deck JH, Morshead C, Van der Kooy D, Evans RJ: Post-herpetic neuralgia: Further post-mortem studies of cases with and without pain. Pain 1991;44:105-117.
9. Ochoa J: The newly recognized painful ABC syndrome: Thermographic aspects. Thermology 1986;2:65.
10. Herweh C, Kress B, Rasche D, Tronnier V, Troger J, Sartor K, Stippich C: Loss of anisotrophy in trigeminal neuralgia revealed by diffusion tensor imaging. Neurology 2007;68: 776-778. (Pubitemid 46667905)
11. Hughes DI, Scott DT, Todd AJ, Riddell JS: Lack of evidence for sprouting of A beta afferents into the superficial laminas of the spinal cord dorsal horn after nerve section. J Neurosci 2003; 23:9491-9499. (Pubitemid 37352049)
12. Fields HL, Rowbotham M, Baron R: Post herpetic neuralgia: Irritable nociceptors and deafferentation. Neurobiol Dis 1998;209-227. (Pubitemid 28519152)
13. Rowbotham MC, Peterson KL, Fields HL: Is post herpetic neuralgia more than one disorder? Pain Forum 1998;7: 231-237.
14. Bowsher D: Pathophysiology of post herpetic neuralgia: Towards a rational treatment. Neurology 1995 Dec;45(12 Suppl 8):S56-57. (Pubitemid 26163689)
15. Oster G, Harding G, Dukes E, Edelsberg J, Cleary PD: Pain medication use, and health related neuralgia: Results from a population-based survey. J Pain 2005;6:356-363.
16. Schmader K: Herpes zoster in the elderly issues related to geriatrics. Clin Infect Dis 1999;28:736-739. (Pubitemid 29169407)
17. Chidiac C, Bruxelle J, Daures JP, Hoang-Xuan T, Morel P, Lepiege A, Hasnaoui A El, de Labareyre C: Presentation to practitioners in France. Clin Infect Dis 2001;33:62-69.
18. Schott GD: Triggering of delayed onset post herpetic neuralgia. Lancet 1998;351:419-420.
19. Bennett GJ: Neuropathic pain: An overview. In: Borsook D (ed): Molecular Neurobiology of Pain. Seattle, WA: IASP Press 1997, pp. 109-113.
20. Bowsher D: The lifetime occurrence of herpes zoster and prevalence of post herpetic neuralgia: Retrospective survey in an elderly population. Eur J Pain 1999;3:335-342. (Pubitemid 30056166)
21. Wood MJ, Kay R, Dworkin RH, Soong SJ, Whitley RJ: Oral acyclovir therapy accelerates pain resolution in patients with herpes zoster: A meta analysis of placebo controlled trials. Clin Infect Dis 1996;22:341-347. (Pubitemid 26056166)
22. Dworkin RH, Schmader KE: The epidemiology and natural history of herpes zoster and post herpetic neuralgia. In: Watson CP, Gershon AA (eds): Herpes Zoster and Post herpetic Neuralgia, 2nd Revised and Enlarged Edition. New York: Elsevier, 2001, pp. 39-64.
23. Watson CPN, Watt VR, Chipman M, Birkett N, Evans RJ: The prognosis with post herpetic neuralgia. Pain 1991;46: 195-199.
24. Helgason S, Peturrson G, Gudmundsson S, Sigurdsson JA: Prevalence of post herpetic neuralgia after the first episode of herpes zoster: Prospective study with long term follow up. BMJ 2000;321:794-796.
25. Ragozzino MW, Melton LJ III, Kurland LT, et al. Chu CP, Perry HO: Population-based study of herpes zoster and its sequelae. Medicine (Baltimore) 1982;61:310-316. (Pubitemid 12031812)
26. De Moragas M, Kierland RR: The outcome of patients with herpes zoster. Arch Derm 1957;75:193-196.
27. Kost RG, Straus SE: Post herpetic neuralgia. Pathogenesis, treatment, and prevention. N Engl J Med 1996;335:32-42.
28. Dworkin, RH, Boon, RJ, Griffin DR, Phung D: Post herpetic neuralgia: Impact of famciclovir, age, rash severity, and acute pain in the herpes zoster patients. J Infect Dis 1998;178(Suppl 1):S76.
29. Nagasako EM, Johnson RW, Griffin DR, Dworkin RH: Rash severity in the herpes zoster: Correlates and relationship to post herpetic neuralgia. J Am Acad Dermatol 2002;46:834.
30. Whitely RJ, Weiss HL, Soong SJ, Gnann JW: Herpes Zoster: Risk categories for persistent pain. J Infect Dis 1999;179:9.
31. Jung BF, Johnson RW, Griffin DR, Dworkin RH: Risk factors for post herpetic neuralgia in patients with herpes zoster. Neurology 2004;62:1545.
32. Ragozzino MW, Melton LJ III, Kurland LT, et al. Populationbased study of herpes zoster and its sequelae. Medicine (Baltimore) 1982;61:310.
33. Bowsher D: The effects of pre-emptive treatment of post herpetic neuralgia with amitriptyline: A randomized, double- blind, placebo-controlled trial. J Pain Symptom Manage 1997;13:327.
34. Meier T, Wasner G, Faust M, Kuntzer T, Ochsner F, Hueppe M, Bogousslaversusky J, Baron R: Efficacy of lidocaine patch 5% in the treatment of neuropathic pain syndromes: A randomized, double-blind, placebo-controlled study. Pain 2003;106:151-158. (Pubitemid 37329625)
35. Galer BS, Rowbotham MC, Perander J, Friedman E: Topical lidocaine patch relieves post herpetic neuralgia more effectively than a vehicle topical patch: Results of an enriched enrollment study. Pain 1999;80:533-538. (Pubitemid 29182702)
36. Davies PS, Galer BS: Review of lidocaine patch 5% studies in the treatment of posthepetic neuralgia. Drugs 2004;64:937-947. (Pubitemid 38608473)
37. Gammaitoni AR, Alvarez NA, Galer BS: Safety and tolerability of the lidocaine patch 5%, a targeted peripheral analgesic. A review of the literature. J Clin Pharmacol 2003; 43:111-117. (Pubitemid 36125935)
38. Watson CP, Tyler KL, Bickers DR, Millikan LE, Smith S, Coleman E: A randomized vehicle-controlled trial of topical capsaicin in the treatment of postherpertic neuralgia. Clin Ther 1993;15:510-526. (Pubitemid 23194627)
39. Backonja MM, Malan TP, Vanhove GF, Tobias JK: NGX- 4010, a high concentration capsaicin patch, for the treatment of post herpetic neuralgia: A randomized, double-blind, controlled study with an open label extension. Pain Med 2010;11:600-608.
40. De Benedittis G, Lorenzetti A: Topical aspirin/diethyl ether mixture versus indomethacin and diclofenac/diethyl ether mixtures for acute herpetic neuralgia and post herpetic neuralgia. A double-blind crossover placebo-controlled study. Pain 1996;65:45-52.
41. Hempenstall K, Nurmikko TJ, Johnson RW, et al A'Hern RP, Rice AS: Analgesic therapy in post herpetic neuralgia: A quantitative systematic review. PLOS Med 2005;2:e164.
42. Bennett MI, Simpson KH: Gabapentin in the treatment of neuropathic pain. Palliat Med 2001;18:5-11.
43. Rowbotham MC, Harden N, Stacey B, Bernstein P, Magnus- Miller L: Gabapentin for the treatment of post herpetic neuralgia: A randomized controlled trial. JAMA 1998;280:1837-1842. (Pubitemid 28544424)
44. Rice ASC, Maton S: Post herpetic Neuralgia Study Group. Gabapentin in post herpetic neuralgia: A randomized, double blind, placebo-controlled study. Pain 2001;94:215-224.
45. Collins SL, Moore RA, McQuay HJ, Wiffen P: Antidepressant and anticonvulsants for diabetic neuropathy and post herpetic neuralgia: A quantitative systematic review. J Pain 2000;20:449-458.
46. Frampton JE, Foster RH: Pregabalin in the treatment of post herpetic neuralgia. Drugs 2005;65:111-118. (Pubitemid 40143809)
47. Kochar D, Garg P, Bumb RA, Kochar SK, Mehta RD, Beniwal R, Rawat N: Divalproex sodium in the management of post herpetic neuralgia: A randomized double blind placebo- controlled study. Q J Med 2005;98:29.
48. Baranowski AP, De Courcey J, Bonello E: A trial of intravenous lidocaine on the pain and allodynia of post herpetic neuralgia. J Pain Symptom Manage 1999;17:429-433. (Pubitemid 29289769)
49. Sindrup SH, Jensen TS: Efficacy of pharmacological treatments of neuropathic pain: An update and effect related to mechanism of drug action. Pain 1999;83:389-400.
50. Watson CP, Vernich L, Chipman M, Reed K: Nortriptyline vs Amitriptyline in post herpetic neuralgia. A randomized controlled trial. Neurology 1998;51:1161-1171.
51. Dworkin RH, O' Connor AB, Backonja M, Farrar JT, Finnerup NB, Jensen TS, Kalso EA, Loeser JD, Miaskowski C, Nurmikko TJ, Portenoy RK, Rice AS, Stacey BR, Treede RD, Turk DC, Wallace MS: Pharmacological management of neuropathic pain: Evidence-based recommendations. Pain 2007;132:237-251. (Pubitemid 350051570)
52. Attal N, Cruccu G, Haanpaa M, Hansson P, Jensen TS, Nurmikko T, Sampaio C, Sindrup S, Wiffen P; EFNS Task Force: EFNS guidelines on pharmacological treatment of neuropathic pain. Eur J Neurol 2006;13:1153-1169. (Pubitemid 44581463)
53. Moulin DE, Clark AJ, Gilron I, Ware MA, Watson CP, Sessle BJ, Coderre T, Morley-Forster PK, Stinson J, Boulanger A, Peng P, Finley GA, Taenzer P, Squire P, Dion D, Cholkan A, Gilani A, Gordon A, Henry J, Jovey R, Lynch M, Mailis- Gagnon A, Panju A, Rollman GB, Velly A; Canadian Pain Society: Pharmacological management of chronic neuropathic pain. Consensus statement and guidelines from the Canadian Pain Society. Pain Res Manage 2007;12:13-21. (Pubitemid 46744774)
54. Watson CP, Babul N: Efficacy of oxycodone in neuropathic pain: A randomized trial in post herpetic neuralgia. Neurology 1998;50:1837-1841. (Pubitemid 28283261)
55. Raja SN, Haythornthwaite JA, Pappagllo M, Clark MR, Travison TG, Sabeen S, Royall RM, Max MB: Opioids versus antidepressants in post herpetic neuralgia: A randomized, placebo-controlled trial. Neurology 2002; 59:1015-1021.
56. Boureau F, Legallicier P, Kabir-Ahmadi M: Tramadol in post herpetic neuralgia: A randomized, double blind, placebocontrolled trial. Pain 2003;104:323-331.
57. Hatrick C, Van Hove I, Stegmann JU, Oh C, Upmalis D: Efficacy and tolerability of tapentadol immediate release and oxycodone HCL immediate release in patients awaiting primary joint replacement surgery for end-stage joint disease: A ten-day, phase-3, randomized, double-blind-and placebo-controlled study. Clin Ther 2009;31:260-271.
58. Gilron I, Bailey JM, Tu D, Holden RR, Weaver DF, Houlden RL: Morphine, gabapentin, or their combination for neuropathic pain. N Eng J Med 2005;352:1324-1334. (Pubitemid 40411499)
59. Kumar V, Krone K, Mathieu A: Neuraxial and sympathetic blocks in herpes zoster and post herpetic neuralgia: An appraisal of current evidence. Reg Anesth Pain 2004;29:454-461. (Pubitemid 39221893)
60. Doi K, Nikai T, Sakura S, Saito Y: Intercostal nerve block with 5% tetracaine for chronic pain syndromes. J Clin Anesth 2002;14:39-41. (Pubitemid 34173611)
61. Kotani N, Kushikata T, Hashimoto H, Kimura F, Muraoka M, Yodono M, Asai M, Matsuki A: Intrathecal Methyprednisolone for intrectable post herpetic neuralgia. N Eng J Med 2000;343:1514-1519.
62. Harke H, Gretenkorte P, Ulrich L, Koester P, Rahman S: Spinal cord stimulation in post herpetic neuralgia and in acute herpes zoster pain. Anesth Analg 2002;94:694-700. (Pubitemid 34177574)
63. Barnard D, Lloyd J, Evans J: Cryoanalgesia in the management of chronic facial pain. J Maxillofac Surg 1981;9:101.
64. Jones MJ, Murrin KR: Intercostal block with cryotherapy. Ann R Coll Surg Engl 1987;69:261.
65. Head H, Campbell A: The pathology of herpes zoster and its bearing on sensory localization. Brain 1900;23:353-532.
66. Oaklander AL: The pathology of shingles: Head and Campbell's 1900 monograph. Arch Neurol 1999;56:1292-1294.
67. Noordenbos W: Post herpetic neuralgia. In: Pain Problems Pertaining To The Transmission Of Nerve Impulses Which Give Rise To Pain. Amsterdam, The Netherlands: Elsevier, 1959, pp. 4-10.
68. Melzack R, Wall P: Pain mechanisms: A new theory. Science 1965;150:971-979.